Animal Models of T Cell-Mediated Skin Diseases
Pharmaceutical companies are spending increasing amounts of money on drug discovery and development. Nevertheless, attrition rates in clinical development are still very high, and up to 90% of new compounds fail in clinical phase I - III trials, which is partially due to lack of clinical efficacy. T...
Saved in:
Corporate Author: | |
---|---|
Other Authors: | , , |
Format: | Electronic eBook |
Language: | English |
Published: |
Berlin, Heidelberg :
Springer Berlin Heidelberg : Imprint: Springer,
2005.
|
Edition: | 1st ed. 2005. |
Series: | Ernst Schering Foundation Symposium Proceedings,
50 |
Subjects: | |
Online Access: | https://doi.org/10.1007/b138119 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|